Afternoon Symposium - ABOG Foundation - Kenneth J. Ryan Ethics Symposium: Incidental Findings in the Era of Whole Genome Sequencing
Time:11:15 am - 1:15 pm
Location:Hawaii Convention Center
Paula Amato, M.D. (Chair), Oregon Health & Science University
Laurence B. McCullough, Ph.D., Baylor College of Medicine
John J. Hutton, M.D., University of Cincinnati College of Medicine
Supported by a 2013 endowment from the American Board of Obstetrics and Gynecology
Needs Assessment and Description
Genetic testing is playing an increasingly important role in medically assisted reproduction. Clinicians should be familiar with currently available genetic tests, their limitations, and ethical challenges.
At the conclusion of this session, participants should be able to:
- Review clinical genetic testing methodologies.
- Provide guidelines for the appropriate use of genetic tests.
- Discuss ethical issues related to genetic testing.Discuss adverse genetic outcomes of assisted reproductive technology (ART).
Both the American College of Obstetricians and Gynecologists (ACOG) and the American College of Medical Genetics (ACMG) recommend that fragile X carrier screening be offered to:
a. Only those with a family history of fragile X
b. Only those with ovarian insufficiency
c. Only those who request it
d. All couples, regardless of race/ethnicity
e. Those with a family history of fragile X, undiagnosed mental retardation/developmental delay/autism, or those with ovarian insufficiency